How Syndromic Molecular Diagnostics is Replacing Traditional Panel-Based Ordering of Infectious Disease Tests
Dublin, Nov. 16, 2020 (GLOBE NEWSWIRE) -- The "Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization 2021 - 2025" report has been added to ResearchAndMarkets.com's offering.
How will COVID-19 affect Syndromic and Infectious Disease Diagnostics? The COVID pandemic is ushering in a new world of infectious disease diagnostics. Infectious disease Dx is changing and will change more in the future. Can a rapidly growing market expand even faster? Find out all about it in this comprehensive report on Syndromic Multiplex Diagnostics.
Are targeted tests for specific pathogens going to be obsolete? Will diagnostics replace physicians? Will Infectious Disease testing move into the Physician's Office or even the Home?
Syndromic testing is proving itself in the market. Players are reporting double-digit growth. Lowering costs, improving outcomes and even helping in the battle against Anti-Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success. It could possibly displace most frontline test protocols AND save money at the same time.
The report forecasts the market size out to 2024. In a special section the report looks at the numbers on how syndromic molecular diagnostics is replacing traditional panel-based ordering of infectious disease tests.
Key Topics Covered:
1. Introduction and Market Definition
2. The Infectious Diseases - Guide to the Pathogens
3. Industry Overview
4. Market Trends
5. Syndromic Testing Recent Developments
6. The Global Market for Syndromic Multiplex Diagnostics
7. Global Syndromic Multiplex Markets - By Syndrome
8. Global MDx Infectious Disease Markets - by Place
Companies Mentioned
Abbott Diagnostics (Alere)
Accelerate Diagnostics
Ador Diagnostics
Akkoni Biosystems
Alveo Technologies
Applied BioCode
Atlas Genetics
Aus Diagnostics
BD Diagnostics
Bio-Rad Laboratories
Biocartis
BioFire Diagnostics
bioMerieux
Bosch Healthcare Solutions GmbH
Cepheid
Cue Health
Curetis
Diagenode Diagnostics
Diasorin
Expedeon
Fusion Genomics
GenePOC Diagnostics
Genetic Signatures
GenMark Dx
Hologic
Immunexpress
Inflammatix
Invetech
Janssen Diagnostics
Karius
Lexigene
Luminex
Mbio Diagnostics
Meridian Bioscience
Mesa Biotech
Mobidiag
Nanomix
Novacyt
Oxford Nanopore
Panagene
Primerdesign
Prominex
Qiagen (Statdx)
Quantumdx
Quidel
Roche Molecular Diagnostics
Saw Diagnostics
Seegene
Sensovation
Siemens Healthineers (Fast Track Diagnostics)
SkylineDx
Sona Nanotech
SpeeDx
T2 Biosystems
Thermo Fisher
Veramarx
XCR Diagnostics
For more information about this report visit https://www.researchandmarkets.com/r/2hw9p7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900